(3R,4S,5R,6R)-3,4,5-Tris[(trimethylsilyl)oxy]-6-{[(trimethylsilyl)oxy]methyl}tetrahydro-2H-pyran-2-on NEW

Get Latest Price

Min. Order1kg
Purity99.9%
Cas No32384-65-9
Supply Ability＞500kg
Update time2023-11-01

Hangzhou ICH Biofarm Co., Ltd

1YR

China

Since2006-07-19

Address1306 Block A, Dragon Times Building, 18 Wantang Road, Hangzhou,310013 CHINA

show less show more

Chemical Properties

Product Name	(3R,4S,5R,6R)-3,4,5-Tris[(trimethylsilyl)oxy]-6-{[(trimethylsilyl)oxy]methyl}tetrahydro-2H-pyran-2-on
CAS No	32384-65-9
EC-No
Min. Order	1kg
Purity	99.9%
Supply Ability	＞500kg
Release date	2023/11/01

(3R,4S,5R,6R)-3,4,5-Tris[(trimethylsilyl)oxy]-6-{[(trimethylsilyl)oxy]methyl}tetrahydro-2H-pyran-2-on is a chemical compound with the following properties:

- Molecular formula: C18H42O6Si4

- Molecular weight: 466.87 g/mol

- Boiling point: 417°C

- Density: 0.97 g/mL

- Flash point: 171°C

- Storage temperature: Under inert gas (nitrogen or argon) at 2-8°C

- Solubility: Sparingly in chloroform, slightly in ethyl acetate and methanol

- Stability: Moisture sensitive

This compound is usually used as an intermediate and raw material in the synthesis of sodium-glucose transporter inhibitors, such as dapagliflozin, empagliflozin, and canagliflozin.

These drugs are used to treat type 2 diabetes by reducing the reabsorption of glucose in the kidneys and increasing its excretion in the urine.

show less show more

Company Profile Introduction

Our company specializes in the research, development and production of APIs and pharmaceutical intermediates. At the same time, our core R&D team has more than 20 years of drug R&D experience. Under the support of a good research and development environment and a professional technical team, our company has obtained rich experience and outstanding achievements of new drugs and generic drugs projects. On the one hand, we are focused on the research and development and the optimization of production processes of generic drugs such as anti-viral and anti-malaria. On the other hand, we are also committed to the cooperative development of innovative drugs in the fields of respiratory system and hypoglycemia. We can provide technical support in all key links of drug research and development for drug production and distribution companies.